0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Viral Vector and Plasmid DNA Testing Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-27P7859
Home | Market Reports | Science| Biological Sciences
Global and Japan Viral Vector and Plasmid DNA Testing Service Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Viral Vector and Plasmid DNA Testing Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-27P7859
Report
October 2024
Pages:127
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Viral Vector and Plasmid DNA Testing Service - Market Size

The global market for Viral Vector and Plasmid DNA Testing Service was estimated to be worth US$ 234.5 million in 2023 and is forecast to a readjusted size of US$ 1039.6 million by 2030 with a CAGR of 23.5% during the forecast period 2024-2030

Viral Vector and Plasmid DNA Testing Service - Market

Viral Vector and Plasmid DNA Testing Service - Market

Viral vectors are widely used in gene therapies. The viral vectors are majorly used by researchers to deliver genetic materials in the cells. Viral vectors are playing significant role in the pharmaceutical sector, as many research and innovations are ongoing for the development of drugs for treating cancer, cardiovascular diseases, ophthalmology, hematology, and many others.
The Viral Vector and Plasmid DNA Testing Service market is driven by the increasing demand for accurate and reliable testing services to ensure the safety and quality of gene therapies and vaccines using viral vectors and plasmid DNA. Testing services play a crucial role in assessing the potency, purity, and identity of these biopharmaceutical products before clinical use. The growing focus on gene-based therapies and the development of innovative treatments for various diseases contribute to market growth. Moreover, regulatory requirements mandating stringent testing standards further propel adoption. However, challenges include the complexity of testing methods and the need for specialized expertise and equipment. Addressing potential cross-contamination, ensuring consistency in testing results, and adhering to evolving regulatory guidelines are ongoing concerns. The market's success relies on continuous research to develop advanced testing methodologies, robust quality control measures, and collaborations between testing laboratories and pharmaceutical companies to offer accurate, efficient, and compliant viral vector and plasmid DNA testing services while navigating the evolving challenges associated with biopharmaceutical testing.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Viral Vector and Plasmid DNA Testing Service, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Viral Vector and Plasmid DNA Testing Service by region & country, by Type, and by Application.
The Viral Vector and Plasmid DNA Testing Service market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viral Vector and Plasmid DNA Testing Service.
Market Segmentation

Scope of Viral Vector and Plasmid DNA Testing Service - Market Report

Report Metric Details
Report Name Viral Vector and Plasmid DNA Testing Service - Market
Forecasted market size in 2030 US$ 1039.6 million
CAGR 23.5%
Forecasted years 2024 - 2030
Segment by Type:
  • Safety
  • Genetic Characterization
  • Purity
  • Identity
  • Potency
Segment by Application
  • Research Organizations
  • Pharmaceutical
  • Biotechnological Companies
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company BioReliance, Cobra Biologics, Oxford BioMedica, UniQure, FinVector, MolMed, MassBiologics, Richter-Helm, FUJIFILM Diosynth Biotechnologies, Lonza, Aldevron, Eurogentec, Cell and Gene Therapy Catapult, Biovian, Brammer Bio
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Viral Vector and Plasmid DNA Testing Service manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Viral Vector and Plasmid DNA Testing Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Viral Vector and Plasmid DNA Testing Service in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Viral Vector and Plasmid DNA Testing Service - Market size in 2030?

Ans: The Viral Vector and Plasmid DNA Testing Service - Market size in 2030 will be US$ 1039.6 million.

Who are the main players in the Viral Vector and Plasmid DNA Testing Service - Market report?

Ans: The main players in the Viral Vector and Plasmid DNA Testing Service - Market are BioReliance, Cobra Biologics, Oxford BioMedica, UniQure, FinVector, MolMed, MassBiologics, Richter-Helm, FUJIFILM Diosynth Biotechnologies, Lonza, Aldevron, Eurogentec, Cell and Gene Therapy Catapult, Biovian, Brammer Bio

What are the Application segmentation covered in the Viral Vector and Plasmid DNA Testing Service - Market report?

Ans: The Applications covered in the Viral Vector and Plasmid DNA Testing Service - Market report are Research Organizations, Pharmaceutical, Biotechnological Companies

What are the Type segmentation covered in the Viral Vector and Plasmid DNA Testing Service - Market report?

Ans: The Types covered in the Viral Vector and Plasmid DNA Testing Service - Market report are Safety, Genetic Characterization, Purity, Identity, Potency

1 Market Overview
1.1 Viral Vector and Plasmid DNA Testing Service Product Introduction
1.2 Global Viral Vector and Plasmid DNA Testing Service Market Size Forecast
1.3 Viral Vector and Plasmid DNA Testing Service Market Trends & Drivers
1.3.1 Viral Vector and Plasmid DNA Testing Service Industry Trends
1.3.2 Viral Vector and Plasmid DNA Testing Service Market Drivers & Opportunity
1.3.3 Viral Vector and Plasmid DNA Testing Service Market Challenges
1.3.4 Viral Vector and Plasmid DNA Testing Service Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Viral Vector and Plasmid DNA Testing Service Players Revenue Ranking (2023)
2.2 Global Viral Vector and Plasmid DNA Testing Service Revenue by Company (2019-2024)
2.3 Key Companies Viral Vector and Plasmid DNA Testing Service Manufacturing Base Distribution and Headquarters
2.4 Key Companies Viral Vector and Plasmid DNA Testing Service Product Offered
2.5 Key Companies Time to Begin Mass Production of Viral Vector and Plasmid DNA Testing Service
2.6 Viral Vector and Plasmid DNA Testing Service Market Competitive Analysis
2.6.1 Viral Vector and Plasmid DNA Testing Service Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Viral Vector and Plasmid DNA Testing Service Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vector and Plasmid DNA Testing Service as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Safety
3.1.2 Genetic Characterization
3.1.3 Purity
3.1.4 Identity
3.1.5 Potency
3.2 Global Viral Vector and Plasmid DNA Testing Service Sales Value by Type
3.2.1 Global Viral Vector and Plasmid DNA Testing Service Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Viral Vector and Plasmid DNA Testing Service Sales Value, by Type (2019-2030)
3.2.3 Global Viral Vector and Plasmid DNA Testing Service Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Research Organizations
4.1.2 Pharmaceutical
4.1.3 Biotechnological Companies
4.2 Global Viral Vector and Plasmid DNA Testing Service Sales Value by Application
4.2.1 Global Viral Vector and Plasmid DNA Testing Service Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Viral Vector and Plasmid DNA Testing Service Sales Value, by Application (2019-2030)
4.2.3 Global Viral Vector and Plasmid DNA Testing Service Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Viral Vector and Plasmid DNA Testing Service Sales Value by Region
5.1.1 Global Viral Vector and Plasmid DNA Testing Service Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Viral Vector and Plasmid DNA Testing Service Sales Value by Region (2019-2024)
5.1.3 Global Viral Vector and Plasmid DNA Testing Service Sales Value by Region (2025-2030)
5.1.4 Global Viral Vector and Plasmid DNA Testing Service Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Viral Vector and Plasmid DNA Testing Service Sales Value, 2019-2030
5.2.2 North America Viral Vector and Plasmid DNA Testing Service Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Viral Vector and Plasmid DNA Testing Service Sales Value, 2019-2030
5.3.2 Europe Viral Vector and Plasmid DNA Testing Service Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Viral Vector and Plasmid DNA Testing Service Sales Value, 2019-2030
5.4.2 Asia Pacific Viral Vector and Plasmid DNA Testing Service Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Viral Vector and Plasmid DNA Testing Service Sales Value, 2019-2030
5.5.2 South America Viral Vector and Plasmid DNA Testing Service Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Viral Vector and Plasmid DNA Testing Service Sales Value, 2019-2030
5.6.2 Middle East & Africa Viral Vector and Plasmid DNA Testing Service Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Viral Vector and Plasmid DNA Testing Service Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Viral Vector and Plasmid DNA Testing Service Sales Value
6.3 United States
6.3.1 United States Viral Vector and Plasmid DNA Testing Service Sales Value, 2019-2030
6.3.2 United States Viral Vector and Plasmid DNA Testing Service Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Viral Vector and Plasmid DNA Testing Service Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Viral Vector and Plasmid DNA Testing Service Sales Value, 2019-2030
6.4.2 Europe Viral Vector and Plasmid DNA Testing Service Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Viral Vector and Plasmid DNA Testing Service Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Viral Vector and Plasmid DNA Testing Service Sales Value, 2019-2030
6.5.2 China Viral Vector and Plasmid DNA Testing Service Sales Value by Type (%), 2023 VS 2030
6.5.3 China Viral Vector and Plasmid DNA Testing Service Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Viral Vector and Plasmid DNA Testing Service Sales Value, 2019-2030
6.6.2 Japan Viral Vector and Plasmid DNA Testing Service Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Viral Vector and Plasmid DNA Testing Service Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Viral Vector and Plasmid DNA Testing Service Sales Value, 2019-2030
6.7.2 South Korea Viral Vector and Plasmid DNA Testing Service Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Viral Vector and Plasmid DNA Testing Service Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Viral Vector and Plasmid DNA Testing Service Sales Value, 2019-2030
6.8.2 Southeast Asia Viral Vector and Plasmid DNA Testing Service Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Viral Vector and Plasmid DNA Testing Service Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Viral Vector and Plasmid DNA Testing Service Sales Value, 2019-2030
6.9.2 India Viral Vector and Plasmid DNA Testing Service Sales Value by Type (%), 2023 VS 2030
6.9.3 India Viral Vector and Plasmid DNA Testing Service Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 BioReliance
7.1.1 BioReliance Profile
7.1.2 BioReliance Main Business
7.1.3 BioReliance Viral Vector and Plasmid DNA Testing Service Products, Services and Solutions
7.1.4 BioReliance Viral Vector and Plasmid DNA Testing Service Revenue (US$ Million) & (2019-2024)
7.1.5 BioReliance Recent Developments
7.2 Cobra Biologics
7.2.1 Cobra Biologics Profile
7.2.2 Cobra Biologics Main Business
7.2.3 Cobra Biologics Viral Vector and Plasmid DNA Testing Service Products, Services and Solutions
7.2.4 Cobra Biologics Viral Vector and Plasmid DNA Testing Service Revenue (US$ Million) & (2019-2024)
7.2.5 Cobra Biologics Recent Developments
7.3 Oxford BioMedica
7.3.1 Oxford BioMedica Profile
7.3.2 Oxford BioMedica Main Business
7.3.3 Oxford BioMedica Viral Vector and Plasmid DNA Testing Service Products, Services and Solutions
7.3.4 Oxford BioMedica Viral Vector and Plasmid DNA Testing Service Revenue (US$ Million) & (2019-2024)
7.3.5 UniQure Recent Developments
7.4 UniQure
7.4.1 UniQure Profile
7.4.2 UniQure Main Business
7.4.3 UniQure Viral Vector and Plasmid DNA Testing Service Products, Services and Solutions
7.4.4 UniQure Viral Vector and Plasmid DNA Testing Service Revenue (US$ Million) & (2019-2024)
7.4.5 UniQure Recent Developments
7.5 FinVector
7.5.1 FinVector Profile
7.5.2 FinVector Main Business
7.5.3 FinVector Viral Vector and Plasmid DNA Testing Service Products, Services and Solutions
7.5.4 FinVector Viral Vector and Plasmid DNA Testing Service Revenue (US$ Million) & (2019-2024)
7.5.5 FinVector Recent Developments
7.6 MolMed
7.6.1 MolMed Profile
7.6.2 MolMed Main Business
7.6.3 MolMed Viral Vector and Plasmid DNA Testing Service Products, Services and Solutions
7.6.4 MolMed Viral Vector and Plasmid DNA Testing Service Revenue (US$ Million) & (2019-2024)
7.6.5 MolMed Recent Developments
7.7 MassBiologics
7.7.1 MassBiologics Profile
7.7.2 MassBiologics Main Business
7.7.3 MassBiologics Viral Vector and Plasmid DNA Testing Service Products, Services and Solutions
7.7.4 MassBiologics Viral Vector and Plasmid DNA Testing Service Revenue (US$ Million) & (2019-2024)
7.7.5 MassBiologics Recent Developments
7.8 Richter-Helm
7.8.1 Richter-Helm Profile
7.8.2 Richter-Helm Main Business
7.8.3 Richter-Helm Viral Vector and Plasmid DNA Testing Service Products, Services and Solutions
7.8.4 Richter-Helm Viral Vector and Plasmid DNA Testing Service Revenue (US$ Million) & (2019-2024)
7.8.5 Richter-Helm Recent Developments
7.9 FUJIFILM Diosynth Biotechnologies
7.9.1 FUJIFILM Diosynth Biotechnologies Profile
7.9.2 FUJIFILM Diosynth Biotechnologies Main Business
7.9.3 FUJIFILM Diosynth Biotechnologies Viral Vector and Plasmid DNA Testing Service Products, Services and Solutions
7.9.4 FUJIFILM Diosynth Biotechnologies Viral Vector and Plasmid DNA Testing Service Revenue (US$ Million) & (2019-2024)
7.9.5 FUJIFILM Diosynth Biotechnologies Recent Developments
7.10 Lonza
7.10.1 Lonza Profile
7.10.2 Lonza Main Business
7.10.3 Lonza Viral Vector and Plasmid DNA Testing Service Products, Services and Solutions
7.10.4 Lonza Viral Vector and Plasmid DNA Testing Service Revenue (US$ Million) & (2019-2024)
7.10.5 Lonza Recent Developments
7.11 Aldevron
7.11.1 Aldevron Profile
7.11.2 Aldevron Main Business
7.11.3 Aldevron Viral Vector and Plasmid DNA Testing Service Products, Services and Solutions
7.11.4 Aldevron Viral Vector and Plasmid DNA Testing Service Revenue (US$ Million) & (2019-2024)
7.11.5 Aldevron Recent Developments
7.12 Eurogentec
7.12.1 Eurogentec Profile
7.12.2 Eurogentec Main Business
7.12.3 Eurogentec Viral Vector and Plasmid DNA Testing Service Products, Services and Solutions
7.12.4 Eurogentec Viral Vector and Plasmid DNA Testing Service Revenue (US$ Million) & (2019-2024)
7.12.5 Eurogentec Recent Developments
7.13 Cell and Gene Therapy Catapult
7.13.1 Cell and Gene Therapy Catapult Profile
7.13.2 Cell and Gene Therapy Catapult Main Business
7.13.3 Cell and Gene Therapy Catapult Viral Vector and Plasmid DNA Testing Service Products, Services and Solutions
7.13.4 Cell and Gene Therapy Catapult Viral Vector and Plasmid DNA Testing Service Revenue (US$ Million) & (2019-2024)
7.13.5 Cell and Gene Therapy Catapult Recent Developments
7.14 Biovian
7.14.1 Biovian Profile
7.14.2 Biovian Main Business
7.14.3 Biovian Viral Vector and Plasmid DNA Testing Service Products, Services and Solutions
7.14.4 Biovian Viral Vector and Plasmid DNA Testing Service Revenue (US$ Million) & (2019-2024)
7.14.5 Biovian Recent Developments
7.15 Brammer Bio
7.15.1 Brammer Bio Profile
7.15.2 Brammer Bio Main Business
7.15.3 Brammer Bio Viral Vector and Plasmid DNA Testing Service Products, Services and Solutions
7.15.4 Brammer Bio Viral Vector and Plasmid DNA Testing Service Revenue (US$ Million) & (2019-2024)
7.15.5 Brammer Bio Recent Developments
8 Industry Chain Analysis
8.1 Viral Vector and Plasmid DNA Testing Service Industrial Chain
8.2 Viral Vector and Plasmid DNA Testing Service Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Viral Vector and Plasmid DNA Testing Service Sales Model
8.5.2 Sales Channel
8.5.3 Viral Vector and Plasmid DNA Testing Service Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Viral Vector and Plasmid DNA Testing Service Market Trends
    Table 2. Viral Vector and Plasmid DNA Testing Service Market Drivers & Opportunity
    Table 3. Viral Vector and Plasmid DNA Testing Service Market Challenges
    Table 4. Viral Vector and Plasmid DNA Testing Service Market Restraints
    Table 5. Global Viral Vector and Plasmid DNA Testing Service Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Viral Vector and Plasmid DNA Testing Service Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Viral Vector and Plasmid DNA Testing Service Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Viral Vector and Plasmid DNA Testing Service Product Type
    Table 9. Key Companies Time to Begin Mass Production of Viral Vector and Plasmid DNA Testing Service
    Table 10. Global Viral Vector and Plasmid DNA Testing Service Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vector and Plasmid DNA Testing Service as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Viral Vector and Plasmid DNA Testing Service Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Viral Vector and Plasmid DNA Testing Service Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Viral Vector and Plasmid DNA Testing Service Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Viral Vector and Plasmid DNA Testing Service Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Viral Vector and Plasmid DNA Testing Service Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Viral Vector and Plasmid DNA Testing Service Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Viral Vector and Plasmid DNA Testing Service Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Viral Vector and Plasmid DNA Testing Service Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Viral Vector and Plasmid DNA Testing Service Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Viral Vector and Plasmid DNA Testing Service Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Viral Vector and Plasmid DNA Testing Service Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Viral Vector and Plasmid DNA Testing Service Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Viral Vector and Plasmid DNA Testing Service Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Viral Vector and Plasmid DNA Testing Service Sales Value by Region (2019-2024) & (%)
    Table 27. Global Viral Vector and Plasmid DNA Testing Service Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Viral Vector and Plasmid DNA Testing Service Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Viral Vector and Plasmid DNA Testing Service Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Viral Vector and Plasmid DNA Testing Service Sales Value, (2025-2030) & (US$ Million)
    Table 31. BioReliance Basic Information List
    Table 32. BioReliance Description and Business Overview
    Table 33. BioReliance Viral Vector and Plasmid DNA Testing Service Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Viral Vector and Plasmid DNA Testing Service Business of BioReliance (2019-2024)
    Table 35. BioReliance Recent Developments
    Table 36. Cobra Biologics Basic Information List
    Table 37. Cobra Biologics Description and Business Overview
    Table 38. Cobra Biologics Viral Vector and Plasmid DNA Testing Service Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Viral Vector and Plasmid DNA Testing Service Business of Cobra Biologics (2019-2024)
    Table 40. Cobra Biologics Recent Developments
    Table 41. Oxford BioMedica Basic Information List
    Table 42. Oxford BioMedica Description and Business Overview
    Table 43. Oxford BioMedica Viral Vector and Plasmid DNA Testing Service Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Viral Vector and Plasmid DNA Testing Service Business of Oxford BioMedica (2019-2024)
    Table 45. Oxford BioMedica Recent Developments
    Table 46. UniQure Basic Information List
    Table 47. UniQure Description and Business Overview
    Table 48. UniQure Viral Vector and Plasmid DNA Testing Service Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Viral Vector and Plasmid DNA Testing Service Business of UniQure (2019-2024)
    Table 50. UniQure Recent Developments
    Table 51. FinVector Basic Information List
    Table 52. FinVector Description and Business Overview
    Table 53. FinVector Viral Vector and Plasmid DNA Testing Service Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Viral Vector and Plasmid DNA Testing Service Business of FinVector (2019-2024)
    Table 55. FinVector Recent Developments
    Table 56. MolMed Basic Information List
    Table 57. MolMed Description and Business Overview
    Table 58. MolMed Viral Vector and Plasmid DNA Testing Service Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Viral Vector and Plasmid DNA Testing Service Business of MolMed (2019-2024)
    Table 60. MolMed Recent Developments
    Table 61. MassBiologics Basic Information List
    Table 62. MassBiologics Description and Business Overview
    Table 63. MassBiologics Viral Vector and Plasmid DNA Testing Service Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Viral Vector and Plasmid DNA Testing Service Business of MassBiologics (2019-2024)
    Table 65. MassBiologics Recent Developments
    Table 66. Richter-Helm Basic Information List
    Table 67. Richter-Helm Description and Business Overview
    Table 68. Richter-Helm Viral Vector and Plasmid DNA Testing Service Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Viral Vector and Plasmid DNA Testing Service Business of Richter-Helm (2019-2024)
    Table 70. Richter-Helm Recent Developments
    Table 71. FUJIFILM Diosynth Biotechnologies Basic Information List
    Table 72. FUJIFILM Diosynth Biotechnologies Description and Business Overview
    Table 73. FUJIFILM Diosynth Biotechnologies Viral Vector and Plasmid DNA Testing Service Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Viral Vector and Plasmid DNA Testing Service Business of FUJIFILM Diosynth Biotechnologies (2019-2024)
    Table 75. FUJIFILM Diosynth Biotechnologies Recent Developments
    Table 76. Lonza Basic Information List
    Table 77. Lonza Description and Business Overview
    Table 78. Lonza Viral Vector and Plasmid DNA Testing Service Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Viral Vector and Plasmid DNA Testing Service Business of Lonza (2019-2024)
    Table 80. Lonza Recent Developments
    Table 81. Aldevron Basic Information List
    Table 82. Aldevron Description and Business Overview
    Table 83. Aldevron Viral Vector and Plasmid DNA Testing Service Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Viral Vector and Plasmid DNA Testing Service Business of Aldevron (2019-2024)
    Table 85. Aldevron Recent Developments
    Table 86. Eurogentec Basic Information List
    Table 87. Eurogentec Description and Business Overview
    Table 88. Eurogentec Viral Vector and Plasmid DNA Testing Service Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Viral Vector and Plasmid DNA Testing Service Business of Eurogentec (2019-2024)
    Table 90. Eurogentec Recent Developments
    Table 91. Cell and Gene Therapy Catapult Basic Information List
    Table 92. Cell and Gene Therapy Catapult Description and Business Overview
    Table 93. Cell and Gene Therapy Catapult Viral Vector and Plasmid DNA Testing Service Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Viral Vector and Plasmid DNA Testing Service Business of Cell and Gene Therapy Catapult (2019-2024)
    Table 95. Cell and Gene Therapy Catapult Recent Developments
    Table 96. Biovian Basic Information List
    Table 97. Biovian Description and Business Overview
    Table 98. Biovian Viral Vector and Plasmid DNA Testing Service Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Viral Vector and Plasmid DNA Testing Service Business of Biovian (2019-2024)
    Table 100. Biovian Recent Developments
    Table 101. Brammer Bio Basic Information List
    Table 102. Brammer Bio Description and Business Overview
    Table 103. Brammer Bio Viral Vector and Plasmid DNA Testing Service Products, Services and Solutions
    Table 104. Revenue (US$ Million) in Viral Vector and Plasmid DNA Testing Service Business of Brammer Bio (2019-2024)
    Table 105. Brammer Bio Recent Developments
    Table 106. Key Raw Materials Lists
    Table 107. Raw Materials Key Suppliers Lists
    Table 108. Viral Vector and Plasmid DNA Testing Service Downstream Customers
    Table 109. Viral Vector and Plasmid DNA Testing Service Distributors List
    Table 110. Research Programs/Design for This Report
    Table 111. Key Data Information from Secondary Sources
    Table 112. Key Data Information from Primary Sources
    Table 113. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Viral Vector and Plasmid DNA Testing Service Product Picture
    Figure 2. Global Viral Vector and Plasmid DNA Testing Service Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Viral Vector and Plasmid DNA Testing Service Sales Value (2019-2030) & (US$ Million)
    Figure 4. Viral Vector and Plasmid DNA Testing Service Report Years Considered
    Figure 5. Global Viral Vector and Plasmid DNA Testing Service Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Viral Vector and Plasmid DNA Testing Service Revenue in 2023
    Figure 7. Viral Vector and Plasmid DNA Testing Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Safety Picture
    Figure 9. Genetic Characterization Picture
    Figure 10. Purity Picture
    Figure 11. Identity Picture
    Figure 12. Potency Picture
    Figure 13. Global Viral Vector and Plasmid DNA Testing Service Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Viral Vector and Plasmid DNA Testing Service Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Product Picture of Research Organizations
    Figure 16. Product Picture of Pharmaceutical
    Figure 17. Product Picture of Biotechnological Companies
    Figure 18. Global Viral Vector and Plasmid DNA Testing Service Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 19. Global Viral Vector and Plasmid DNA Testing Service Sales Value Market Share by Application, 2023 & 2030
    Figure 20. North America Viral Vector and Plasmid DNA Testing Service Sales Value (2019-2030) & (US$ Million)
    Figure 21. North America Viral Vector and Plasmid DNA Testing Service Sales Value by Country (%), 2023 VS 2030
    Figure 22. Europe Viral Vector and Plasmid DNA Testing Service Sales Value (2019-2030) & (US$ Million)
    Figure 23. Europe Viral Vector and Plasmid DNA Testing Service Sales Value by Country (%), 2023 VS 2030
    Figure 24. Asia Pacific Viral Vector and Plasmid DNA Testing Service Sales Value (2019-2030) & (US$ Million)
    Figure 25. Asia Pacific Viral Vector and Plasmid DNA Testing Service Sales Value by Country (%), 2023 VS 2030
    Figure 26. South America Viral Vector and Plasmid DNA Testing Service Sales Value (2019-2030) & (US$ Million)
    Figure 27. South America Viral Vector and Plasmid DNA Testing Service Sales Value by Country (%), 2023 VS 2030
    Figure 28. Middle East & Africa Viral Vector and Plasmid DNA Testing Service Sales Value (2019-2030) & (US$ Million)
    Figure 29. Middle East & Africa Viral Vector and Plasmid DNA Testing Service Sales Value by Country (%), 2023 VS 2030
    Figure 30. Key Countries/Regions Viral Vector and Plasmid DNA Testing Service Sales Value (%), (2019-2030)
    Figure 31. United States Viral Vector and Plasmid DNA Testing Service Sales Value, (2019-2030) & (US$ Million)
    Figure 32. United States Viral Vector and Plasmid DNA Testing Service Sales Value by Type (%), 2023 VS 2030
    Figure 33. United States Viral Vector and Plasmid DNA Testing Service Sales Value by Application (%), 2023 VS 2030
    Figure 34. Europe Viral Vector and Plasmid DNA Testing Service Sales Value, (2019-2030) & (US$ Million)
    Figure 35. Europe Viral Vector and Plasmid DNA Testing Service Sales Value by Type (%), 2023 VS 2030
    Figure 36. Europe Viral Vector and Plasmid DNA Testing Service Sales Value by Application (%), 2023 VS 2030
    Figure 37. China Viral Vector and Plasmid DNA Testing Service Sales Value, (2019-2030) & (US$ Million)
    Figure 38. China Viral Vector and Plasmid DNA Testing Service Sales Value by Type (%), 2023 VS 2030
    Figure 39. China Viral Vector and Plasmid DNA Testing Service Sales Value by Application (%), 2023 VS 2030
    Figure 40. Japan Viral Vector and Plasmid DNA Testing Service Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Japan Viral Vector and Plasmid DNA Testing Service Sales Value by Type (%), 2023 VS 2030
    Figure 42. Japan Viral Vector and Plasmid DNA Testing Service Sales Value by Application (%), 2023 VS 2030
    Figure 43. South Korea Viral Vector and Plasmid DNA Testing Service Sales Value, (2019-2030) & (US$ Million)
    Figure 44. South Korea Viral Vector and Plasmid DNA Testing Service Sales Value by Type (%), 2023 VS 2030
    Figure 45. South Korea Viral Vector and Plasmid DNA Testing Service Sales Value by Application (%), 2023 VS 2030
    Figure 46. Southeast Asia Viral Vector and Plasmid DNA Testing Service Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Southeast Asia Viral Vector and Plasmid DNA Testing Service Sales Value by Type (%), 2023 VS 2030
    Figure 48. Southeast Asia Viral Vector and Plasmid DNA Testing Service Sales Value by Application (%), 2023 VS 2030
    Figure 49. India Viral Vector and Plasmid DNA Testing Service Sales Value, (2019-2030) & (US$ Million)
    Figure 50. India Viral Vector and Plasmid DNA Testing Service Sales Value by Type (%), 2023 VS 2030
    Figure 51. India Viral Vector and Plasmid DNA Testing Service Sales Value by Application (%), 2023 VS 2030
    Figure 52. Viral Vector and Plasmid DNA Testing Service Industrial Chain
    Figure 53. Viral Vector and Plasmid DNA Testing Service Manufacturing Cost Structure
    Figure 54. Channels of Distribution (Direct Sales, and Distribution)
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Medical Silicone Anatomy Models Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-31W18780
Fri Jan 31 00:00:00 UTC 2025

Add to Cart

Global Silicone Anatomy Models Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15X18988
Fri Jan 31 00:00:00 UTC 2025

Add to Cart

Global Computer-Assisted Protein Expression Design (CAPE) Platform Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29K18604
Fri Jan 31 00:00:00 UTC 2025

Add to Cart

Global Intracortical Brain-Computer Interfaces Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-17Q19071
Fri Jan 24 00:00:00 UTC 2025

Add to Cart